Karel Everaert Selected Research

Nocturia

5/2021	Nocturia through the menopausal transition and beyond: a narrative review.
1/2021	Nocturia is Associated with High Atherosclerotic Cardiovascular Disease Risk in Women: Results from the National Health and Nutrition Examination Survey.
1/2021	Characterizing nocturia among Belgian healthy postmenopausal women: Prevalence, degree of bother, etiology and risk factors for nocturia.
1/2021	Nocturia and electrocardiographic abnormalities among patients at an inner-city cardiology clinic.
1/2021	Hormone therapy as a possible solution for postmenopausal women with nocturia: results of a pilot trial.
12/2020	Dutch version of the TANGO nocturia screening tool: cross-culturally translation and reliability study in community-dwelling people and nursing home residents.
8/2020	Could Evening Dietary Protein Intake Play a Role in Nocturnal Polyuria?
1/2020	Dietary considerations in the evaluation and management of nocturia.
1/2020	Nocturia and Nocturnal Polyuria in Neurological Patients: From Epidemiology to Treatment. A Systematic Review of the Literature.
1/2020	Nocturia: a marker of furosemide treatment response? An exploratory study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Karel Everaert Research Topics

Disease

19	Nocturia 05/2021 - 08/2015
17	Polyuria 06/2022 - 10/2013
9	Overactive Urinary Bladder (Overactive Bladder) 01/2022 - 12/2010
7	Urinary Incontinence 01/2022 - 07/2005
4	Edema (Dropsy) 01/2021 - 01/2019
4	Hypertension (High Blood Pressure) 01/2021 - 02/2017
4	Varicocele 10/2016 - 04/2005
3	Sleep Wake Disorders 05/2021 - 02/2017
3	Urinary Tract Infections (Urinary Tract Infection) 07/2020 - 12/2010
3	Neurogenic Urinary Bladder (Bladder, Neurogenic) 11/2012 - 02/2006
2	Heart Failure 01/2021 - 01/2020
2	Lower Urinary Tract Symptoms 10/2020 - 11/2017
2	Diabetes Insipidus 01/2020 - 01/2020
2	Obstructive Sleep Apnea 01/2019 - 02/2017
2	Urinary Retention 01/2017 - 12/2010
2	Cystitis 01/2007 - 01/2003
2	Pyelonephritis 01/2007 - 01/2003
2	Prostatitis 01/2007 - 01/2003
2	Azoospermia 03/2006 - 04/2005
1	Enuresis 06/2022
1	Nocturnal Enuresis (Bedwetting) 04/2021
1	Diabetes Mellitus 01/2021
1	Obesity 01/2021
1	Chronic Renal Insufficiency 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2020
1	Stroke (Strokes) 01/2020
1	Sleep Apnea Syndromes (Sleep Apnea) 01/2020
1	Kidney Diseases (Kidney Disease) 01/2020
1	Weight Loss (Weight Reduction) 12/2019
1	Dementia (Dementias) 08/2019
1	Renal Insufficiency (Renal Failure) 01/2019
1	Polydipsia 01/2019
1	Spinal Cord Injuries (Spinal Cord Injury) 01/2019
1	Intervertebral Disc Degeneration 07/2017
1	Renal Colic 06/2017
1	Ataxia (Dyssynergia) 04/2017
1	Paraplegia (Spastic Paraplegia) 04/2017
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 10/2016
1	Body Weight (Weight, Body) 09/2015

Drug/Important Bio-Agent (IBA)

9	SodiumIBA 01/2020 - 08/2015
7	DiureticsIBA 01/2021 - 02/2017
6	Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric 11/2019 - 09/2015
5	Hormones (Hormone)IBA 01/2021 - 02/2016
5	Type A Botulinum Toxins (Botox)FDA Link 04/2017 - 07/2005
3	Vasopressins (Vasopressin)IBA 06/2022 - 11/2019
3	CreatinineIBA 12/2019 - 01/2003
3	Cholinergic Antagonists (Anticholinergics)IBA 01/2017 - 12/2010
2	Estrogens (Estrogen)FDA Link 05/2021 - 01/2021
2	Arginine Vasopressin (Argipressin)IBA 01/2021 - 11/2019
2	Urea (Carbamide)FDA LinkGeneric 08/2020 - 01/2017
2	Dietary SodiumIBA 01/2020 - 01/2020
2	Solifenacin Succinate FDA Link 01/2020 - 01/2017
2	Testosterone (Sustanon)FDA Link 10/2016 - 04/2005
2	EnbucrilateIBA 03/2014 - 06/2012
2	AlbuminsIBA 01/2007 - 01/2003
2	Proteins (Proteins, Gene)FDA Link 01/2007 - 01/2003
1	salicylhydroxamic acid (SHAM)IBA 04/2021
1	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2021
1	ORALIT (ORS)IBA 01/2021
1	SolutionsIBA 01/2021
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 12/2020
1	Dietary ProteinsIBA 08/2020
1	incobotulinumtoxinA FDA Link 04/2020
1	MelatoninIBA 01/2020
1	rotigotine FDA Link 01/2020
1	Furosemide (Lasix)FDA LinkGeneric 01/2020
1	Deuterium Oxide (Heavy Water)IBA 01/2020
1	ElectrolytesIBA 01/2020
1	TeaIBA 01/2020
1	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 01/2020
1	PotassiumIBA 12/2019
1	SaltsIBA 09/2019
1	HaptoglobinsIBA 09/2019
1	Indicators and Reagents (Reagents)IBA 08/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Dichlorodiphenyldichloroethane (DDD)IBA 07/2017
1	ElementsIBA 06/2017
1	Analgesics (Analgesic Drugs)IBA 06/2017
1	Blood Glucose (Blood Sugar)IBA 02/2017
1	Muscarinic AntagonistsIBA 02/2017
1	GATIBA 10/2016
1	TabletsIBA 09/2015
1	AngiotensinsIBA 11/2014
1	CyanoacrylatesIBA 03/2014

Therapy/Procedure

15	Therapeutics 01/2022 - 02/2006
3	Home Nursing (Nursing, Home) 12/2020 - 10/2013
2	Suburethral Slings (Tension-Free Vaginal Tape) 01/2022 - 11/2012
2	Drug Therapy (Chemotherapy) 01/2021 - 11/2019
2	Catheters 07/2020 - 09/2013
2	Continuous Positive Airway Pressure 01/2020 - 02/2017
1	Prostatectomy (Retropubic Prostatectomy) 01/2022
1	Aftercare (After-Treatment) 01/2021
1	Diet Therapy (Therapy, Diet) 01/2020
1	Hormone Replacement Therapy (Therapy, Hormone Replacement) 08/2019
1	Denervation 01/2019
1	Conservative Treatment 01/2019
1	Analgesia 06/2017
1	Injections 04/2017
1	Artificial Urinary Sphincter 10/2016
1	Local Anesthesia 03/2014